Global /United States /Healthcare /Medical Devices /ECOR
chevron_leftBack
electroCore, Inc. logo

electroCore, Inc.

ECOR
NASDAQ: ECOR Delayed
6.33USD 2.9%
As of 14 June 2026, electroCore, Inc. has a market cap of $51.17M USD, ranking #30429 globally and #4449 in the United States. It ranks #2750 in the Healthcare sector, and #569 in the Medical Devices industry.
Global Rank
30429
Country Rank
4449
Sector Rank
2750
Industry Rank
569
Key Stats
Market Cap
$51.17MUSD
Enterprise Value
$47.51MUSD
Revenue (TTM)
$32.03MUSD
EBITDA (TTM)
-$12.65MUSD
Net Income (TTM)
-$13.97MUSD
EBITDA Margin
-39%
Profit Margin
-44%
PS Ratio
1.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Medical Devices
CEO
Daniel Goldberger open_in_new
Employees
83
Founded
2005
IPO
22 Jun 2018
Website
electrocore.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
2.9% -0.6% 5.2% -15% 27% -16%

News

Loading...

ECOR Analyst Forecasts

Loading...

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
ECOR
electroCore Inc
ISIN: US28531P2020
Shares Out.:
8.296M1 Shares Float: 5.123M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
6.33 USD
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About electroCore, Inc.

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Similar Companies

Industry: Medical Devices (United States)
Name
Market Cap diff.
PE
$173.27B
339K%
25.8
$160.73B
314K%
56.7
$159.07B
311K%
25.6
DHR
$126.55B
247K%
34.7
SYK
$120.69B
236K%
38.3
$84.93B
166K%
24.5
Industry: Medical Devices (Global)
Name
Market Cap diff.
PE
MDT
$101.9B
199K%
22.2
$97.46B
84.32B EUR
190K%
36.7
7741
$61.41B
9.83T JPY
120K%
40.0
$45.47B
39.34B EUR
89K%
18.7
ALC
$36.38B
28.99B CHF
71K%
37.9
$30.06B
203.66B CNY
59K%
26.0
chevron_leftBack